Khan Bilal Arshad bought SGP
February 9, 2026 · Form 4 insider transaction
Khan Bilal Arshad bought 115,000 shares of SpyGlass Pharma, Inc. at $16.00 per share, a transaction worth $1.84M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
115,000
Price
$16.00
Total value
$1.84M
InsiderKhan Bilal Arshad
RoleDirector
CompanySpyGlass Pharma, Inc. (SGP)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after251,427
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Shares held by New World Medical, Inc. (New World Medical). The Reporting Person is the Chief Executive Officer of New World Medical and as such has voting and investment control over the shares held by New World Medical. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest in the shares.